Botox May Reshape the Brain’s Finger Maps in Focal Hand Dystonia, 7T MRI Reveals

Focal hand dystonia is one of neurology’s most frustrating disorders: a hand that once played a violin, typed fluently, or simply held a pen begins to curl and spasm against its owner’s will. The standard treatment, botulinum toxin injected into the overactive muscles, dulls the spasms for a few months but does nothing obviously to the brain. Or so it was thought. A team at the University of Nottingham’s Sir Peter Mansfield Imaging Centre has now used ultra-high-field 7 Tesla functional MRI to peer into the somatosensory cortex of people with focal hand dystonia at two points in their treatment cycle, and the results hint that the toxin’s effects may reach all the way into how the cortex represents touch. The study, published in the journal Dystonia, offers some of the sharpest images yet of the brain’s finger maps in this condition.

The cortical territory devoted to each finger is tiny, occupying millimetre-scale patches along a folded strip of tissue called the primary somatosensory cortex, tucked into the postcentral gyrus. Resolving individual finger representations demands both exceptional spatial resolution and clever experimental design. Earlier studies, many conducted at 3 Tesla or below, reported that dystonia patients had blurred, overlapping finger maps, with reduced distances between neighbouring digit representations. Those findings have been increasingly questioned, because coarse resolution and volumetric analyses can distort measurements across the brain’s folds. The Nottingham group therefore turned to 7T fMRI, whose stronger magnetic field yields greater blood-oxygenation-level-dependent contrast and finer spatial detail, and analysed the data on the cortical surface rather than in three-dimensional volume space.

The experimental centerpiece was a travelling-wave paradigm. Piezoelectric stimulators attached to the fingertips vibrated each digit in turn at 30 hertz in a smoothly cycling sequence, so that the phase of the fMRI signal in each cortical vertex encoded which finger it represented. Fourier analysis of the resulting time series produced coherence and phase maps tracing the orderly progression from thumb to little finger. The researchers also ran a motor travelling-wave task on the dominant hand, compared every participant’s maps against a probabilistic digit atlas built from healthy volunteers, and fitted a one-dimensional Gaussian population receptive field model to estimate how broadly each cortical location responded to touch.

Four patients with focal hand dystonia, all with writer’s cramp affecting their dominant hand, completed the full protocol twice: once roughly thirty days after a botulinum toxin injection, at peak drug efficacy, and again roughly one hundred days after treatment, just before their next injection when the therapeutic effect had waned. Age- and sex-matched healthy controls were scanned once. Alongside imaging, participants completed behavioural tests of temporal discrimination, vibrotactile amplitude detection, and spatial acuity using a grating orientation task, in which participants judge the orientation of ridged domes pressed against a fingertip. Ten additional volunteers repeated the behavioural battery two weeks apart so that the team could verify each measure’s repeatability.

On the behavioural side, one result stood out clearly. Spatial acuity, measured by the grating orientation task, was significantly worse in the dystonic, dominant hand than in controls, at both post-treatment and pre-treatment visits. Temporal discrimination and amplitude detection, by contrast, showed no significant differences between groups, likely reflecting the greater variability of those measures and the small sample. The repeatability checks confirmed that the grating task was by far the most stable behavioural metric, with a within-participant coefficient of variation of just over six percent, making it a reliable probe of the sensory deficits that many researchers now consider central to dystonia’s pathophysiology.

Inside the scanner, the headline finding was nuanced. Contrary to the earliest reports of widespread map collapse, the digit maps of dystonia patients retained their classic thumb-to-little-finger ordering in both somatosensory and motor cortex, and looked qualitatively similar to those of healthy volunteers. But quantitative comparisons told a subtler story. Dice coefficients, which quantify the spatial overlap between each participant’s digit regions of interest and a reference, were significantly lower for the affected dominant hand than for the non-dominant hand, in both the somatosensory and motor tasks, when patients were compared with controls. A figure-of-merit summary that penalises degenerate, overlapping representations confirmed the pattern. The cortex had not scrambled its hand, but the affected hand’s representation was measurably more disordered or variable.

The population receptive field analysis delivered the study’s most striking treatment-related result. In the period just before the next injection, when botulinum toxin’s effects had declined, patients’ pRF sizes in the dominant hand were significantly larger than in controls and than in the same patients at peak treatment. Larger pRFs mean that each cortical patch pools touch information from a wider swath of the fingertip, a blurrier, less finely tuned representation. After treatment, pRF sizes shrank back to values comparable with healthy controls. Notably, the large-scale digit ordering captured by Dice coefficients and central-tendency metrics did not change between visits, suggesting the toxin modulates fine-grained spatial tuning rather than reorganising the map wholesale.

Resting-state fMRI added a network-level perspective. With seeds placed in the postcentral gyrus, the team found reduced functional connectivity between the hemisphere contralateral to the dominant hand and the opposite postcentral gyrus in patients, consistent with prior reports of weakened sensorimotor connectivity in writer’s cramp and other dystonias. No connectivity differences emerged between the two treatment time points, which the authors attribute to the limited statistical power of a four-patient imaging cohort rather than a genuine absence of effect. The findings echo a broader shift in dystonia research away from viewing the disorder as a basal ganglia problem alone and toward understanding it as a disorder of distributed sensorimotor networks.

The implications of the pRF result are provocative. Botulinum toxin acts peripherally, blocking acetylcholine release at the neuromuscular junction and quieting overactive muscles. Yet the cortical tuning it coincided with suggests a central echo of a peripheral intervention: as abnormal muscle activity and afferent feedback subside, the somatosensory cortex may sharpen its receptive fields. This fits accumulating evidence that focal hand dystonia is fundamentally a disorder of abnormal sensorimotor integration, in which distorted sensory input and maladaptive plasticity reinforce each other. If pRF size proves to be a sensitive, treatment-responsive biomarker, it could eventually help clinicians and researchers measure how therapies act on the brain, not just on the muscle.

The authors are candid about the study’s limits. Four patients made it through the strict imaging quality controls, small numbers that constrain statistical power and raise the risk of false positives despite Bonferroni correction, and patient heterogeneity in symptom duration and severity complicates group comparisons. The grating task was administered only to the affected hand, and the motor mapping only to the dominant hand, limiting within-participant comparisons. Larger cohorts, both-hand motor mapping, and correlation of pRF measures with individual symptoms are the obvious next steps. Even so, the study makes a compelling case that 7T fMRI, surface-based analysis, and computational modelling can detect subtle, treatment-linked changes in the brain’s hand map that older techniques missed, and that a drug best known for freezing muscles may quietly retune the cortex that feels them.

Subject of Research: Cortical digit map organisation and botulinum toxin effects in focal hand dystonia measured with 7T functional MRI

Article Title: Assessing the digit organisation of focal hand dystonia using 7T functional MRI

Article References: Asghar, M., Sanchez-Panchuelo, R., Glover, P., Pakenham, D., O’Neill, G. C., Schluppeck, D., Humberstone, M., & Francis, S. (2026). Assessing the digit organisation of focal hand dystonia using 7T functional MRI. Dystonia, 5, Article 15574. https://doi.org/10.3389/dyst.2026.15574

Image Credits: AI Generated

DOI: 10.3389/dyst.2026.15574

Keywords: focal hand dystonia, botulinum toxin, 7T fMRI, somatosensory cortex, digit mapping, population receptive field, writer's cramp, functional connectivity, travelling wave fMRI, spatial acuity, neuroplasticity, Dystonia journal